CollabRx to Present at LD MICRO Invitational on October 2nd

CollabRx to Present at LD MICRO Invitational on October 2nd

SAN FRANCISCO, Sept. 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc.
(Nasdaq:CLRX), a data analytics company focused on informing clinical decision
making in molecular medicine, announces that Thomas R. Mika, Chief Executive
Officer, will present at the LD MICRO Invitational on Wednesday, October 2,
2013 at 1:00 p.m. PST / 4:00 p.m. EST. The conference is being held at the
Luxe Sunset Bel Air Hotel in Los Angeles.

About CollabRx

CollabRx, Inc. (Nasdaq:CLRX) is a recognized leader in cloud-based expert
systems to inform healthcare decision-making. CollabRx uses information
technology to aggregate and contextualize the world's knowledge on
genomics-based medicine with specific insights from the nation's top cancer
experts, starting with the area of greatest need: advanced cancers in patients
who have effectively exhausted the standard of care. More information may be
obtained at http://www.collabrx.com.

About LD MICRO

LD MICRO is a by-invitation only newsletter firm that focuses on finding
undervalued companies in the micro-cap space. Since 2002, the firm has
published an annual list of recommended stocks as well as comprehensive
reports on select companies throughout the year. LD MICRO concentrates on
finding, researching, and investing in companies that are overlooked by
institutional investors. It is a non-registered investment advisor. For more
info, please visit http://www.ldmicro.com

CONTACT: Investor Relations Contacts:
        
         Thomas R. Mika, CEO
         CollabRx, Inc.
         415-248-5350
         or
         James Carbonara, Regional Vice President
         Hayden IR
         646-755-7412
         James@haydenir.com

CollabRx, Inc. Logo